This advanced residency provides specialized training in the care of patients with both solid tumor and hematologic malignancies. During the 12-month ASHP-accredited program, the resident will develop clinical practice skills through direct patient care and didactic learning. Residents will develop proficiencies in teaching and collaborative research throughout the residency as well.
PGY2 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
The resident will be an integral part of the health care team for each service. The resident provides comprehensive pharmaceutical care services, including pharmacotherapy consults, pharmacokinetic analysis, drug information, and intensive monitoring of each patient on service. The resident participates in all aspects of service, education and research in each clinical area.
- Adult Medical Hematology/Oncology
- Hematopoietic Stem Cell Transplant
- Oncology Leadership
- Investigational Drug Services
- Longitudinal Ambulatory Oncology Clinics
- Gynecologic/Surgical Oncology
- Radiation Oncology
- Infectious Diseases
- Pain and Palliative Care
- Malignant Hematology
- Critical Care/Nutrition Support
- Ambulatory (off site; if available)
The resident will:
- Staff an average of eight to twelve hours per week, to include rotation through Oncology On-Call, inpatient and outpatient staffing
- Attend pharmacy and rotation-specific Grand Rounds, conferences, and meetings
- Participate in a committee and hold a pharmacy leadership position
- Gain teaching experience through formal and informal lectures to medical, nursing, and pharmacy staff and students
- Review and present a new drug pertinent to oncology practice, proposed for formulary addition, to the Pharmacy and Therapeutics Committee
- A required research or quality improvement project, which will directly affect oncology patient care and the practice of hospital pharmacy, will enable the resident to develop skills in clinical research, study design and statistical analysis. The project should lead to a manuscript suitable for publication.
- Present this project at a regional residency conference or equivalent
- Develop and present a medication monograph and MUE
- Deliver two formal accredited CE presentations to the pharmacy department
- Participate in preventative/public health activity
- Office space with a personal computer is provided.
- Pagers are provided to all residents.
The resident will receive a $52,000 stipend paid UF Health Shands Hospital. The stipend, coupled with the comparatively low cost of living in Gainesville, should ensure a financially sufficient year.
Hospital benefits include:
- Ten days of paid time off
- Eight paid holidays
- Contributory health insurance
- Paid life insurance
Academic: The applicant should have a Doctor of Pharmacy degree from an accredited school or college. The applicant should have completed a PGY1 Pharmacy Residency before enrolling in this advanced residency program.
Professional License: All residents must be eligible for Florida licensure. Selected and matched residents must be licensed within 90 days of the start of residency.
Interview: An on-site interview with 30 minute presentation is required.
Non-Resident Alien Applicants: To be considered for employment, you must presently have an employment authorization that is valid throughout the residency period.
- Interested applicants must register for the Resident Matching Program
- Submit all applications through PhORCAS.
- Final deadline for complete applications is December 31st, 2021
- Complete applications include:
- Transcript of the applicant’s grades
- Letter of intent
- Current curriculum vitae
- Standardized Reference Forms supplied by and filled out in PhORCAS from three (3) professional sources.
- After completed applications have been reviewed, the residency selection committee will notify selected applicants to arrange an on-site interview.
- Official start date for the residency: July 5th, 2022
Residency Program Director:
- Ashley Richards, PharmD, BCOP
- Sarah Wheeler, PharmD, BCPS, BCOP